Cargando…
The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754967/ https://www.ncbi.nlm.nih.gov/pubmed/32964655 http://dx.doi.org/10.1002/ehf2.13014 |
_version_ | 1783626283187437568 |
---|---|
author | Ren, Qing‐wen Li, Xin‐li Fang, Johnathan Chen, Yan Wu, Mei‐Zhen Yu, Yu‐Juan Liao, Shen‐gen Tse, Hung‐Fat Yiu, Kai‐Hang |
author_facet | Ren, Qing‐wen Li, Xin‐li Fang, Johnathan Chen, Yan Wu, Mei‐Zhen Yu, Yu‐Juan Liao, Shen‐gen Tse, Hung‐Fat Yiu, Kai‐Hang |
author_sort | Ren, Qing‐wen |
collection | PubMed |
description | AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. METHODS AND RESULTS: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow‐up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all‐cause mortality, HF requiring hospitalization and cardiovascular death (log‐rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. CONCLUSIONS: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization. |
format | Online Article Text |
id | pubmed-7754967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77549672020-12-23 The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction Ren, Qing‐wen Li, Xin‐li Fang, Johnathan Chen, Yan Wu, Mei‐Zhen Yu, Yu‐Juan Liao, Shen‐gen Tse, Hung‐Fat Yiu, Kai‐Hang ESC Heart Fail Original Research Articles AIMS: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. METHODS AND RESULTS: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow‐up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all‐cause mortality, HF requiring hospitalization and cardiovascular death (log‐rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. CONCLUSIONS: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization. John Wiley and Sons Inc. 2020-09-23 /pmc/articles/PMC7754967/ /pubmed/32964655 http://dx.doi.org/10.1002/ehf2.13014 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Ren, Qing‐wen Li, Xin‐li Fang, Johnathan Chen, Yan Wu, Mei‐Zhen Yu, Yu‐Juan Liao, Shen‐gen Tse, Hung‐Fat Yiu, Kai‐Hang The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title_full | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title_fullStr | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title_full_unstemmed | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title_short | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
title_sort | prevalence, predictors, and prognosis of tricuspid regurgitation in stage b and c heart failure with preserved ejection fraction |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754967/ https://www.ncbi.nlm.nih.gov/pubmed/32964655 http://dx.doi.org/10.1002/ehf2.13014 |
work_keys_str_mv | AT renqingwen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT lixinli theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT fangjohnathan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT chenyan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT wumeizhen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT yuyujuan theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT liaoshengen theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT tsehungfat theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT yiukaihang theprevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT renqingwen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT lixinli prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT fangjohnathan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT chenyan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT wumeizhen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT yuyujuan prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT liaoshengen prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT tsehungfat prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction AT yiukaihang prevalencepredictorsandprognosisoftricuspidregurgitationinstagebandcheartfailurewithpreservedejectionfraction |